Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R C Bast

Showing results (221-230 of 299) with videos related to

Pageof 30
Sort By:
Gynecologic Oncology|February 1, 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerV J Hunter, J B Weinberg, A F Haney, et al.
Nuclear Medicine and Biology|January 11, 2000
Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distributionM R Zalutsky, F J Xu, Y Yu, et al.
Gynecologic Oncology|August 12, 1998
Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell linesM P Boente, A Berchuck, R S Whitaker, et al.
American Journal of Obstetrics and Gynecology|September 1, 1993
Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasiasM F Kohler, H Nishii, P A Humphrey, et al.
Cancer|June 15, 1993
Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancerS J McKenzie, K A DeSombre, B S Bast, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic studyW P Peters, A Stuart, M Klotman, et al.
American Journal of Obstetrics and Gynecology|December 11, 1992
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cellsM P Boente, A Berchuck, G C Rodriguez, et al.
Nuclear Medicine and Biology|July 1, 1997
Radioiodinated antibody targeting of the HER-2/neu oncoproteinF J Xu, Y H Yu, D S Bae, et al.
Cancer|May 15, 1996
Expression of cell regulatory proteins in ovarian borderline tumorsC van Haaften-Day, P Russell, C M Boyer, et al.
International Journal of Cancer|May 8, 2000
ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancersH Peng, F Xu, R Pershad, et al.
Pageof 30

Showing results (221-230 of 299) with videos related to

Sort By:
Pageof 30
Gynecologic Oncology|February 1, 1990
CA 125 in peritoneal fluid and serum from patients with benign gynecologic conditions and ovarian cancerV J Hunter, J B Weinberg, A F Haney, et al.
Nuclear Medicine and Biology|January 11, 2000
Radioiodinated antibody targeting of the HER-2/neu oncoprotein: effects of labeling method on cellular processing and tissue distributionM R Zalutsky, F J Xu, Y Yu, et al.
Gynecologic Oncology|August 12, 1998
Suppression of diacylglycerol levels by antibodies reactive with the c-erbB-2 (HER-2/neu) gene product p185c-erbB-2 in breast and ovarian cancer cell linesM P Boente, A Berchuck, R S Whitaker, et al.
American Journal of Obstetrics and Gynecology|September 1, 1993
Mutation of the p53 tumor-suppressor gene is not a feature of endometrial hyperplasiasM F Kohler, H Nishii, P A Humphrey, et al.
Cancer|June 15, 1993
Serum levels of HER-2 neu (C-erbB-2) correlate with overexpression of p185neu in human ovarian cancerS J McKenzie, K A DeSombre, B S Bast, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1989
High-dose combination cyclophosphamide, cisplatin, and melphalan with autologous bone marrow support. A clinical and pharmacologic studyW P Peters, A Stuart, M Klotman, et al.
American Journal of Obstetrics and Gynecology|December 11, 1992
The effect of interferon gamma on epidermal growth factor receptor expression in normal and malignant ovarian epithelial cellsM P Boente, A Berchuck, G C Rodriguez, et al.
Nuclear Medicine and Biology|July 1, 1997
Radioiodinated antibody targeting of the HER-2/neu oncoproteinF J Xu, Y H Yu, D S Bae, et al.
Cancer|May 15, 1996
Expression of cell regulatory proteins in ovarian borderline tumorsC van Haaften-Day, P Russell, C M Boyer, et al.
International Journal of Cancer|May 8, 2000
ARHI is the center of allelic deletion on chromosome 1p31 in ovarian and breast cancersH Peng, F Xu, R Pershad, et al.
Pageof 30